The Cigna Group (CI)
'Overuse' is causing healthcare insurer headwinds, says Mizuho's Jared Holz
Jared Holz, Mizuho healthcare equity strategist, joins CNBC's 'The Exchange' to discuss why healthcare insurer stocks are down, whether weight loss drugs have any impact, and more.
Cigna, Humana Merger Discussions Reportedly Revived
Humana (HUM) shares edged higher Monday morning on a report that The Cigna Group (CI) has resumed discussions to buy its smaller health insurance rival after negotiations fell apart last year. Cigna shares declined.
Cigna Restarts Talks To Buy Fallen Star Humana; 2024 Election Is Key
Cigna-Humana merger talks are back on, nearly one year after the first try. The price may be more affordable after CI stock outperformed, while HUM struggled.
Cigna And Humana Revive Early Merger Talks After Year-Long Pause As Medicare Cost Pressure Looms
In a significant development in the health insurance industry, Cigna Group CI has reinitiated discussions to merge with Humana Inc. HUM, potentially creating a giant in the sector.
Cigna, Humana Resume Merger Talks, Report Says. Why It's Different This Time.
Key developments since the talks between the healthcare insurers broke down last year mean a deal now looks more likely.
Potential Cigna buyout of Humana is a ‘when,' not an ‘if,' analyst says
Humana's stock looked to rally Monday. And Mizuho analyst Ann Hynes said she believes a buyout by Cigna Group is likely — it's just a matter of timing.
Cigna resumes merger discussions with Humana, Bloomberg News reports
U.S. health insurer Cigna Group has revived efforts to merge with smaller rival Humana after abandoning the pursuit late last year, Bloomberg News reported on Friday, citing people familiar with the matter.
Cigna Breaks Below 200-Day Moving Average
In trading on Friday, shares of The Cigna Group crossed below their 200 day moving average of $340.21, changing hands as low as $338.60 per share. The Cigna Group shares are currently trading off about 3.8% on the day.
4 HMO Stocks to Watch Despite Continued Industry Headwinds
The Medical-HMO industry is aided by rising health insurance premiums and strategic M&A moves, but faces margin pressure from high-tech costs and staffing shortages. UNH, CI, HUM and MOH are likely to navigate industry storms.
Why Cigna (CI) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cigna seeks to disqualify FTC Chair Lina Khan from insulin case because of alleged bias
Cigna said that Khan, along with Commissioners Rebecca Kelly Slaughter and Alvaro Bedoya, have made repeated and incorrect prejudgments that show bias against pharmacy-benefit managers.
Will Cigna (CI) Beat Estimates Again in Its Next Earnings Report?
Cigna (CI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
